Nilsine Partners LLC Reduces Stock Holdings in Cigna Group (NYSE:CI)

Nilsine Partners LLC trimmed its position in shares of Cigna Group (NYSE:CI - Free Report) by 63.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 974 shares of the health services provider's stock after selling 1,708 shares during the period. Nilsine Partners LLC's holdings in Cigna Group were worth $320,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Two Sigma Investments LP lifted its holdings in shares of Cigna Group by 32.6% in the fourth quarter. Two Sigma Investments LP now owns 764,900 shares of the health services provider's stock worth $211,219,000 after acquiring an additional 188,235 shares during the last quarter. Humankind Investments LLC lifted its holdings in shares of Cigna Group by 12.1% in the fourth quarter. Humankind Investments LLC now owns 5,294 shares of the health services provider's stock worth $1,462,000 after acquiring an additional 571 shares during the last quarter. NBC Securities Inc. bought a new position in shares of Cigna Group in the first quarter worth about $123,000. Pine Valley Investments Ltd Liability Co lifted its holdings in shares of Cigna Group by 10.5% in the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 17,366 shares of the health services provider's stock worth $4,796,000 after acquiring an additional 1,653 shares during the last quarter. Finally, BankPlus Trust Department bought a new position in shares of Cigna Group in the fourth quarter worth about $332,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Trading Up 0.8%

Shares of NYSE:CI traded up $2.65 during midday trading on Monday, reaching $317.00. The company's stock had a trading volume of 1,248,081 shares, compared to its average volume of 1,710,777. The firm has a market capitalization of $84.68 billion, a price-to-earnings ratio of 17.55, a PEG ratio of 0.93 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72. The firm has a 50 day moving average price of $321.24 and a two-hundred day moving average price of $307.52. Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, beating analysts' consensus estimates of $6.35 by $0.39. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The business had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. During the same period in the previous year, the company posted $6.47 EPS. The firm's revenue was up 14.4% compared to the same quarter last year. As a group, analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd were issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.91%. The ex-dividend date of this dividend was Tuesday, June 3rd. Cigna Group's dividend payout ratio is currently 33.44%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Royal Bank Of Canada reiterated an "outperform" rating and issued a $371.00 price objective on shares of Cigna Group in a report on Tuesday, June 3rd. Cowen reiterated a "buy" rating on shares of Cigna Group in a report on Monday, May 5th. Guggenheim reiterated a "buy" rating and issued a $388.00 price objective on shares of Cigna Group in a report on Friday, May 23rd. Truist Financial raised their price objective on shares of Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a report on Monday, May 12th. Finally, Piper Sandler raised their price target on shares of Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Two investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $380.39.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.